HYPOGLYCEMIA AND EXERCISE IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
患有 1 型糖尿病的儿童和青少年的低血糖与运动
基本信息
- 批准号:7374264
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The specific aim of this project is to determine whether in children/adolescents with Type 1 Diabetes, the adaptive glucoregulatory response to exercise is attenuated, contributing to the high incidence of hypoglycemia occurring in this group of patients. In the management of patients with Type 1 diabetes mellitus (T1DM), hypoglycemia is a major clinical problem. Hypoglycemia may disrupt daily activities, cause life-threatening events, induce fetal damage, alter cognitive function in children, and exert long-term negative effects on intellectual function. Hypoglycemia often occurs in association with physical exercise, often forcing patients to renounce several beneficial effects of exercise, including improved insulin sensitivity and glycemic control, and improved control of blood pressure and prevention of cardiovascular disease, for which these patients are at elevated risk. The causes of the recent increase in the indidence of hypoglycemia in patients with T1DM are incompletely understood. Although the recent adoption of more aggressive insulin regimens certainly play a role, it has become clear that a more complex alteration of the patients' ability to react against hypoglycemia is also present. The underlying mechanisms of this phenomenon are still unclear. When hypoglycemia occurs, a series of responses (defined as counter-regulatory responses) are activated, including secretion of glucagon, epinephrine, norepinephrine, cortisol, and growth hormone, which stimulate endogenous glucose production, and can correct hypoglycemia. Activation of these responses, however, may become acutely inadequate if an episode of stress (including hypoglycemia itself) occurred recently before. Patients with T1DM, therefore, who experience frequent, recurrent hypoglycemia, are trapped in a vicious cycle in which each episodes of hypoglycemia weakens responses to a later episode, including more hypoglycemia and so on. Although reversible, this phenomenon practically often results in continuous loss of counter-regulatory competence. During exercise, the skeletal muscle increases its glucose uptake for energy production. As a result, circulating levels of glucose may rapidly decrease. This does not occur, however, over a broad range of exercise intensities and durations, because counter-regulatory responses (similar to those elicited by hypoglycemia) are activated, stimulating endogenous glucose production. Hypoglycemia during exercise, however, may supervene if counter-regulatory responses become acutely inadequate. Acute failure of counter-regulatory responses during exercise may be induced by antecedent hypoglycemia in healthy adults and in adult patients with Type 1 diabetes. Further, exercise is also known to acutely increase insulin sensitivity. Modulation of the exercise-induced increase in insulin-sensitivity may be a mechanism by which exercise-associated hypoglycemia is favored by a prior stress. The above blunting effects of prior stress on subsequent exercise have only been observed in adults. It is important, however, to determining whether these concepts also apply to children who, among patients with T1DM, display the highest incidence of hypoglycemia. A 6.5 year follow-up in the Diabetes Control and Complication Trial showed that severe hypoglycemia occurred 27.8 times/100 patients/year in conventionally treated adolescents 18.7 times in conventionally treated adults, and 85.7 times in intensively treated adolescents. In the same study, hypoglycemic coma or seizures occurred 5.4 times/100 patients/year in conventionally treated adolescents and 16.3 times in intensively treated adolescents. Children/adolescents are also the most physically active age group, and not surprisingly T1DM children present with a high prevalence of exercise-related hypoglycemia. Hypoglycemia may occur during, 1-2 hours after, or 10-17 hours after exercise. Often hypoglycemia occurs during sleep in the night following the exercise activity. Adaptation to exercise also elicits a broader series of responses, including secretion of inflammatory cytokines and growth factors. Although many of these agents often display glucoregulatory activity, their role as possible regulators of glucose homeostasis during stress has not been studied. The pro-inflammatory IL-6 is the most abundantly elevated cytokine during exercise. Beyond its immunoregulatory properties, IL-6 can also stimulate secretion of catecholamines, cortisol, GH and glucagon, and may have also direct glucoregulatory effect, as proven in several in vitro studies. It was therefore recently hypothesized that the IL-6 produced by active skeletal muscle may partly mediate glucose homeostasis during exercise. The growth hormone --> insulin-like growth factor I (GH --> IGF-I) axis is a key regulator of systemic anabolism. During exercise GH increases, but IGF-I levels remain substantially constant, despite significant changes in most of its regulatory factors (insulin, GH, IL-6, IGF BP-1). In children this may be viewed as an attempt to preserve the anabolic/developmental effects of IGF-1, while avoiding perturbations in glucose homeostasis due to its insulin-like effects. Although both GH (which stimulates IGF-I), and insulin (whose reduction stimulates IGF BP-1), which in turn inhibits IGF-I responses to exercise are markedly affected by prior hypoglycemia, it is currently unknown whether prior stress affects IGF-I or IGF BP-1 responses in exercise, niether in adults or children. Based on the above considerations, our hypotheses are: a) The adaptive response aimed a maintaining glucose homeostatis during exericse, in addition to neuroendrocrine components (glucagon, catecholamines, cortisol, growth hormone), also includes cytokines (IL-6) and growth factors (IGF-I, IGF BP-1). b) Alterations of this adaptive response may be induced by a prior stress, such as prior hypoglycemia, resulting in inadequate endogenous glucose production (EGP) during exercise and/or changes in the exercise-induced increase in insulin sensitivity. c) In children with T1DM, in particular, exposure to frequent, recurrent hypoglycemia and other chronic stress results in an attenuated adaptive response to exercise, as compared to healthy control children.
该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金,因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构,不一定是研究者的机构。该项目的具体目的是确定患有 1 型糖尿病的儿童/青少年对运动的适应性血糖调节反应是否减弱,从而导致该组患者发生低血糖的高发生率。 在 1 型糖尿病 (T1DM) 患者的治疗中,低血糖是一个主要的临床问题。低血糖可能会扰乱日常活动,导致危及生命的事件,诱发胎儿损伤,改变儿童的认知功能,并对智力功能产生长期负面影响。低血糖通常与体育锻炼有关,常常迫使患者放弃锻炼的一些有益作用,包括改善胰岛素敏感性和血糖控制,以及改善血压控制和预防心血管疾病,而这些患者患上这些疾病的风险较高。 最近 T1DM 患者低血糖发生率增加的原因尚不完全清楚。尽管最近采用的更积极的胰岛素治疗方案确实发挥了作用,但很明显,患者对低血糖的反应能力也存在更复杂的改变。这种现象的根本机制仍不清楚。 当低血糖发生时,一系列反应(定义为反调节反应)被激活,包括胰高血糖素、肾上腺素、去甲肾上腺素、皮质醇和生长激素的分泌,刺激内源性葡萄糖产生,可以纠正低血糖。然而,如果最近发生过压力事件(包括低血糖本身),这些反应的激活可能会变得严重不足。因此,患有频繁、反复低血糖的 T1DM 患者陷入了恶性循环,每次低血糖发作都会削弱对后续发作的反应,包括更多的低血糖等等。尽管这种现象是可逆的,但实际上常常导致反监管能力的持续丧失。 运动期间,骨骼肌增加葡萄糖摄取以产生能量。结果,葡萄糖的循环水平可能迅速下降。然而,在大范围的运动强度和持续时间内,这种情况不会发生,因为反调节反应(类似于低血糖引起的反应)被激活,刺激内源性葡萄糖的产生。然而,如果反调节反应严重不足,运动期间可能会出现低血糖。健康成人和成年 1 型糖尿病患者中,运动过程中反调节反应的急性失败可能是由先前的低血糖引起的。此外,众所周知,运动可以急剧增加胰岛素敏感性。对运动引起的胰岛素敏感性增加的调节可能是先前压力促进运动相关低血糖的一种机制。 上述先前压力对后续运动的减弱作用仅在成年人中观察到。然而,重要的是要确定这些概念是否也适用于 T1DM 患者中低血糖发生率最高的儿童。糖尿病控制和并发症试验的 6.5 年随访显示,在接受常规治疗的青少年中,重度低血糖的发生率为 27.8 次/100 名患者/年,在接受常规治疗的成人中为 18.7 次,在强化治疗的青少年中为 85.7 次。在同一项研究中,在接受常规治疗的青少年中,低血糖昏迷或癫痫发作的发生率为 5.4 次/100 名患者/年,在强化治疗的青少年中为 16.3 次。儿童/青少年也是体力活动最活跃的年龄组,毫不奇怪,T1DM 儿童与运动相关的低血糖患病率很高。低血糖可能发生在运动期间、运动后1-2小时或运动后10-17小时。低血糖通常发生在运动活动后的夜间睡眠期间。 对运动的适应还会引发更广泛的一系列反应,包括炎症细胞因子和生长因子的分泌。尽管这些药物中的许多通常表现出葡萄糖调节活性,但它们作为应激期间葡萄糖稳态调节剂的作用尚未被研究。 促炎性 IL-6 是运动期间升高最多的细胞因子。除了其免疫调节特性外,IL-6 还可以刺激儿茶酚胺、皮质醇、GH 和胰高血糖素的分泌,并且还可能具有直接的葡萄糖调节作用,多项体外研究已证明。因此,最近推测活跃的骨骼肌产生的 IL-6 可能部分介导运动期间的葡萄糖稳态。 生长激素 --> 胰岛素样生长因子 I (GH --> IGF-I) 轴是全身合成代谢的关键调节因子。运动期间 GH 增加,但 IGF-I 水平基本保持恒定,尽管其大多数调节因子(胰岛素、GH、IL-6、IGF BP-1)发生显着变化。在儿童中,这可能被视为试图保留 IGF-1 的合成代谢/发育作用,同时避免因其类胰岛素作用而扰乱葡萄糖稳态。尽管 GH(刺激 IGF-I)和胰岛素(其减少刺激 IGF BP-1)(反过来抑制 IGF-I 对运动的反应)均受到先前低血糖的显着影响,但目前尚不清楚先前的压力是否会影响运动中的 IGF-I 或 IGF BP-1 反应,无论是在成人还是儿童中。 基于上述考虑,我们的假设是: a) 适应性反应旨在维持运动过程中的葡萄糖稳态,除了神经内分泌成分(胰高血糖素、儿茶酚胺、皮质醇、生长激素)外,还包括细胞因子(IL-6)和生长因子(IGF-I、IGF BP-1)。 b) 这种适应性反应的改变可能是由先前的应激引起的,例如先前的低血糖,导致运动期间内源性葡萄糖产生(EGP)不足和/或运动引起的胰岛素敏感性增加的变化。 c) 与健康对照儿童相比,尤其是患有 T1DM 的儿童,频繁、反复发生低血糖和其他慢性压力会导致对运动的适应性反应减弱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PIETRO R GALASSETTI其他文献
PIETRO R GALASSETTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PIETRO R GALASSETTI', 18)}}的其他基金
Inflammatory Biomarkers in Pediatric Obesity and Diabetes: Research and Mentoring
儿童肥胖和糖尿病的炎症生物标志物:研究和指导
- 批准号:
8116070 - 财政年份:2010
- 资助金额:
$ 2万 - 项目类别:
Inflammatory Biomarkers in Pediatric Obesity and Diabetes: Research and Mentoring
儿童肥胖和糖尿病的炎症生物标志物:研究和指导
- 批准号:
8531910 - 财政年份:2010
- 资助金额:
$ 2万 - 项目类别:
Inflammatory Biomarkers in Pediatric Obesity and Diabetes: Research and Mentoring
儿童肥胖和糖尿病的炎症生物标志物:研究和指导
- 批准号:
7989293 - 财政年份:2010
- 资助金额:
$ 2万 - 项目类别:
Inflammatory Biomarkers in Pediatric Obesity and Diabetes: Research and Mentoring
儿童肥胖和糖尿病的炎症生物标志物:研究和指导
- 批准号:
8715773 - 财政年份:2010
- 资助金额:
$ 2万 - 项目类别:
Inflammatory Biomarkers in Pediatric Obesity and Diabetes: Research and Mentoring
儿童肥胖和糖尿病的炎症生物标志物:研究和指导
- 批准号:
8311089 - 财政年份:2010
- 资助金额:
$ 2万 - 项目类别:
HYPOGLYCEMIA AND EXERCISE IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
患有 1 型糖尿病的儿童和青少年的低血糖与运动
- 批准号:
8166897 - 财政年份:2009
- 资助金额:
$ 2万 - 项目类别:
MECHANISMS OF HEALTH EFFECTS OF EXERCISE IN CHILDREN
运动对儿童健康影响的机制
- 批准号:
7956531 - 财政年份:2009
- 资助金额:
$ 2万 - 项目类别:
BIOMARKERS OF GLUCOSE METABOLISM IN EXHALED BREATH
呼出气中葡萄糖代谢的生物标志物
- 批准号:
8166907 - 财政年份:2009
- 资助金额:
$ 2万 - 项目类别:
HYPOGLYCEMIA AND EXERCISE IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
患有 1 型糖尿病的儿童和青少年的低血糖与运动
- 批准号:
7951030 - 财政年份:2008
- 资助金额:
$ 2万 - 项目类别:
相似海外基金
Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program
接触全氟烷基物质对减肥的影响:对参加社区减肥干预计划的超重/肥胖西班牙裔儿童的初步研究
- 批准号:
10724050 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM)
确定青年发病 2 型糖尿病 (IMPACT DM) 的代谢和心理社会因素和特征
- 批准号:
10584028 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention
PreDM:一项针对糖尿病预防的适应性、开放标签试点干预试验
- 批准号:
10457639 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism
星形胶质细胞胰岛素抵抗诱导青春期延迟和低促性腺激素性性腺功能减退症的神经内分泌缺陷
- 批准号:
10392144 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Adapting an Adolescent Weight Management Program for a Type 1 Diabetes Population
针对 1 型糖尿病人群调整青少年体重管理计划
- 批准号:
10689195 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention
PreDM:一项针对糖尿病预防的适应性、开放标签试点干预试验
- 批准号:
10668457 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism
星形胶质细胞胰岛素抵抗诱导青春期延迟和低促性腺激素性性腺功能减退症的神经内分泌缺陷
- 批准号:
10612727 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Alpha Lipoic Acid as a Maternal Supplement in Obese Pregnancies
α-硫辛酸作为肥胖孕妇的母体补充剂
- 批准号:
10573241 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH)
扩大幼儿期家庭检查,促进母婴心血管健康 (ENRICH)
- 批准号:
10427592 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
Role of miRNAs in the transmission of metabolic risks
miRNA 在代谢风险传递中的作用
- 批准号:
10446558 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别: